프로티나

468530KOSDAQ자연과학 및 공학 연구개발업

51.0 / 100

Reference Date: 2026-07-24

Financial Score14.5 / 40

News Sentiment20.4 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is low with sound financial health but PBR raises overvaluation concerns. Plunged 24.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

ProtiNA is a PPI big data company specializing in high-speed, large-scale analysis of protein-protein interactions (PPI) using its proprietary SPID platform. The SPID technology offers up to 100 times higher sensitivity than traditional methods and is applied in drug development, biomarker discovery, and antibody design. The company provides solutions like PPI PathFinder® and PPI Landscape® for pharmaceutical research.

Number of Employees

53people

Average Salary

70.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

8.67Industry Average 2.520.0Point

3.4x industry avg (risky)

ROE

-40.84Industry Average -32.093.5Point

In line with industry avg

Debt Ratio

5.62Industry Average 7.314.0Point

In line with industry avg

Trend 3.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

0.0 / 4

Detailed News Sentiment

11 totalPositive 10Neutral 1Negative 0Average Sentiment Score 81.8

Positive
차세대 항암 신약 공동연구 추진…프로티나 14%↑[특징주]
프로티나의 주가가 온코닉테라퓨틱스와의 공동 신약 연구 발표로 인해 급등했다.
Positive
프로티나, ABX에 34억원 출자…“AI 기반 항체 원천설계 확대”
프로티나의 ABX 바이오사이언시스에 대한 대규모 투자로 AI 기반 신약 개발 역량 강화 기대.
Positive
프로티나, ABX 바이오사이언스에 34억원 출자… 최대주주로 참여
프로티나의 ABX 바이오사이언스에 대한 대규모 투자로 신약 개발 역량 강화 및 사업 확장 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (8%, downtrend)

Current 22,300Won52-week high 111,80052-week low 13,800

1-month return0.0Point

1m -24.15% (strong drop)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral타법인주식및출자증권취득결정2026-07-14
Neutral투자판단관련주요경영사항 (항체 바이오베터 공동기술개발 및 기술이전 옵션 계약 체결)2026-07-09
Neutral기업설명회(IR)개최2026-07-07